Authors:
DAHLEN B
NIZANKOWSKA E
SZCZEKLIK A
ZETTERSTROM O
BOCHENEK G
KUMLIN M
MASTALERZ L
PINIS G
SWANSON LJ
BOODHOO TI
WRIGHT S
DUBE LM
DAHLEN SE
Citation: B. Dahlen et al., BENEFITS FROM ADDING THE 5-LIPOXYGENASE INHIBITOR ZILEUTON TO CONVENTIONAL THERAPY IN ASPIRIN-INTOLERANT ASTHMATICS, American journal of respiratory and critical care medicine, 157(4), 1998, pp. 1187-1194
Citation: Hj. Schwartz et al., A RANDOMIZED CONTROLLED TRIAL COMPARING ZILEUTON WITH THEOPHYLLINE INMODERATE ASTHMA, Archives of internal medicine, 158(2), 1998, pp. 141-148
Authors:
DUBUSKE LM
GROSSMAN J
DUBE LM
SWANSON LJ
LANCASTER JF
BERGER W
CHAROUS BL
CRINER G
DAUL C
EDWARDS T
FINK JN
FLESCHER J
HOWLAND WC
KAISER HB
KORENBLAT PE
KUSSIN PS
LANG D
LIGHT R
NATHAN R
PIEN L
PLATTSMILLS TAE
RAMSDELL J
SCARDELLA AT
SCHENKEL EJ
SELNER J
SILVERS WS
CARPENTIER PJ
SWANSON SW
MANSKI RP
RUFF DD
Citation: Lm. Dubuske et al., RANDOMIZED TRIAL OF ZILEUTON IN PATIENTS WITH MODERATE ASTHMA - EFFECT OF REDUCED DOSING FREQUENCY AND AMOUNTS ON PULMONARY-FUNCTION AND ASTHMA SYMPTOMS, American journal of managed care, 3(4), 1997, pp. 633-640
Authors:
OCONNOR BJ
GODARD P
DUBE LM
SWANSON LJ
MAKI R
Citation: Bj. Oconnor et al., THE COMPARATIVE EFFECT OF ZILEUTON, A 5-LIPOXYGENASE INHIBITOR, PLUS LOW-DOSE INHALED BECLOMETHASONE VS HIGHER DOSE BECLOMETHASONE FOR ASTHMA, Journal of allergy and clinical immunology, 97(1), 1996, pp. 271-271
Authors:
LAURSEN LS
LAURITSEN K
BUKHAVE K
RASKMADSEN J
JACOBSEN O
NAESDAL J
GOEBELL H
PESKAR B
RUBIN PD
SWANSON LJ
KESTERSON JW
KESHAVARZIAN A
KOZAREK R
HANAUER S
CORT D
STENSON WF
Citation: Ls. Laursen et al., SELECTIVE 5-LIPOXYGENASE INHIBITION BY ZILEUTON IN THE TREATMENT OF RELAPSING ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL, European journal of gastroenterology & hepatology, 6(3), 1994, pp. 209-215